CA2167538A1 - Stabilisation de proteines aerosols - Google Patents

Stabilisation de proteines aerosols

Info

Publication number
CA2167538A1
CA2167538A1 CA002167538A CA2167538A CA2167538A1 CA 2167538 A1 CA2167538 A1 CA 2167538A1 CA 002167538 A CA002167538 A CA 002167538A CA 2167538 A CA2167538 A CA 2167538A CA 2167538 A1 CA2167538 A1 CA 2167538A1
Authority
CA
Canada
Prior art keywords
protein
aqueous solution
peg
aerosolized
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002167538A
Other languages
English (en)
Inventor
Tsutomu Arakawa
Ralph W. Niven
Steven J. Prestrelski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2167538A1 publication Critical patent/CA2167538A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Anesthesiology (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Colloid Chemistry (AREA)

Abstract

Procédé de protection de protéines contre la dégradation due à la pulvérisation sous forme d'aérosol et la perte de leur activité protéique. On stabilise les protéines comprises dans l'aérosol en ajoutant à la solution aqueuse, avant sa pulvérisation, un composé polaire organique hydrosoluble, par exemple le polyéthylène-glycol, ou un tensioactif. On a également prévu une solution aqueuse de protéines stabilisées renfermant un composé polaire organique ou un tensioactif, ainsi qu'un système de pulvérisation sous forme d'aérosol de la solution aqueuse renfermant les protéines stabilisées.
CA002167538A 1993-07-19 1994-07-19 Stabilisation de proteines aerosols Abandoned CA2167538A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9384093A 1993-07-19 1993-07-19
US08/093,840 1993-07-19

Publications (1)

Publication Number Publication Date
CA2167538A1 true CA2167538A1 (fr) 1995-02-02

Family

ID=22241106

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002167538A Abandoned CA2167538A1 (fr) 1993-07-19 1994-07-19 Stabilisation de proteines aerosols

Country Status (8)

Country Link
EP (1) EP0710102A1 (fr)
JP (1) JPH09501418A (fr)
AU (1) AU691514B2 (fr)
CA (1) CA2167538A1 (fr)
FI (1) FI960253A7 (fr)
NO (1) NO960217L (fr)
NZ (1) NZ271181A (fr)
WO (1) WO1995003034A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113271A1 (en) * 1997-01-29 2003-06-19 University Technology Corporation Formulations for pulmonary delivery
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
SK11142002A3 (sk) * 1999-12-30 2004-09-08 Chiron Corporation Liečivo na podávanie interleukínu-2 a stabilizovaný lyofilizovaný alebo sprejovo sušený farmaceutický prostriedok s obsahom interleukínu-2
EP1129720B1 (fr) 2000-02-29 2004-06-23 Pfizer Products Inc. Composition stabilisée d'un facteur stimulant les colonies de granulocytes
DE60219961T8 (de) 2001-02-02 2008-04-17 Ortho-Mcneil Pharmaceutical, Inc. Behandlung von neurologischen funktionsstörungen mit fructopyranosesulfamaten und erythropoetin
US20030072717A1 (en) 2001-02-23 2003-04-17 Vapotronics, Inc. Inhalation device having an optimized air flow path
AU2002310054B2 (en) * 2001-05-21 2007-02-01 Injet Digital Aerosols Limited Compositions for protein delivery via the pulmonary route
JP2004087560A (ja) 2002-08-23 2004-03-18 Sansha Electric Mfg Co Ltd 電源装置
EP2220115A2 (fr) * 2007-12-13 2010-08-25 Glaxo Group Limited Polypeptides, domaines variables d'anticorps et antagonistes
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
EP2414560B1 (fr) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Procédé de revêtement d'une surface d'un composant
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (fr) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nébuliseur
BR112012012475B1 (pt) 2009-11-25 2020-03-03 Boehringer Ingelheim International Gmbh Nebulizador
WO2011160932A1 (fr) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nébuliseur
EP2694220B1 (fr) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Appareil médical pourvu d'un récipient
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
JP6019118B2 (ja) 2011-08-02 2016-11-02 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ 吸入に適した酸化型アビジンの医薬品組成物
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
CN116036425A (zh) 2014-05-07 2023-05-02 勃林格殷格翰国际有限公司 喷雾器、指示器装置及容器
IL247927B (en) 2014-05-07 2022-09-01 Boehringer Ingelheim Int Container, a device that turns a liquid into a fine spray and use
WO2015169430A1 (fr) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nébuliseur

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций

Also Published As

Publication number Publication date
EP0710102A1 (fr) 1996-05-08
WO1995003034A1 (fr) 1995-02-02
NZ271181A (en) 1998-06-26
FI960253L (fi) 1996-03-18
JPH09501418A (ja) 1997-02-10
AU7473294A (en) 1995-02-20
FI960253A7 (fi) 1996-03-18
NO960217D0 (no) 1996-01-18
AU691514B2 (en) 1998-05-21
FI960253A0 (fi) 1996-01-18
NO960217L (no) 1996-03-18

Similar Documents

Publication Publication Date Title
AU691514B2 (en) Stabilization of aerosolized proteins
KR100291620B1 (ko) 부갑상선호르몬의활성단편의폐를통한전달방법
JP2747073B2 (ja) ヒト成長ホルモン製剤
CA1222948A (fr) Stimulation de l'absorption intranasale de la calcitonine dans les preparations contenant des surfactants
JP2656944B2 (ja) タンパク質性治療剤のエアロゾール化
AU2002255541B2 (en) Modulated release particles for aerosol delivery
JP2774379B2 (ja) 医薬エアロゾール組成物ならびにそれらのウイルス疾患の治療および予防用途
CN101677947A (zh) 包含胰岛素衍生物的药物制剂
CA2396781A1 (fr) Procede d'administration d'une formulation aerosol medicale
JPH05963A (ja) ポリペプチド類組成物
SA95160483B1 (ar) صيغ رذاذية aerosol formuation من البيبتيدات peptides والبروتينات proteins
JPH0768149B2 (ja) 鼻腔内投与用調製剤およびその製法
AU2002255541A1 (en) Modulated release particles for aerosol delivery
JPH09509927A (ja) 医薬として許容されるｄｎアーゼ配合物
AU2002306462B2 (en) Modulated release particles for aerosol delivery
AU2002306462A1 (en) Modulated release particles for aerosol delivery
US20010055610A1 (en) Medicament administration system
CA2305256C (fr) Suspensions de mometasone furoate pour la nebulisation
US6124257A (en) Method of treatment
HUP0103606A2 (hu) Pulmonáris bejuttatáshoz való, mentolt tartalmazó inzulinkészítmények
Jalalipour et al. Characterization and aerodynamic evaluation of spray dried recombinant human growth hormone using protein stabilizing agents
EP1455764B1 (fr) Compositions medicinales en aerosol contenant un excipient d'amide et/ou d'ester
CA2470520A1 (fr) Compositions aerosols pharmaceutiques comportant un excipient au polyethylene-glycol fonctionnalise
CA2365266A1 (fr) Aliments fonctionnels a base de proteine de soja
WO1982003011A1 (fr) Agent de traitement des maladies des organes respiratoires

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued